Abstract:Colorectal cancer (CRC) has predominantly been considered a genetic disease, characterized by sequential accumulation of genetic alterations. Growing evidence indicates that epigenetic alterations add an additional layer of complexity to the pathogenesis of CRC, and characterize a subgroup of colorectal cancers with a distinct etiology and prognosis. Epigenetic dysregulation in colorectal cancer is organized at multiple levels, involving DNA methylation, histone modifications, nucleosomal occupancy and remodel… Show more
“…Our initial hypothesis was that we would perhaps observe the most noticeable changes in AKBA-induced reversal of methylation in CIMP cell lines due to the high frequency and levels of methylated mono-targeted therapies. 35,36 In light of accumulating evidence and our findings in this study, clinical validation of the efficacy of boswellic acids for both chemoprevention and therapy of CRC could be promising.…”
Section: (B) An Illustration From Ingenuitymentioning
“…Our initial hypothesis was that we would perhaps observe the most noticeable changes in AKBA-induced reversal of methylation in CIMP cell lines due to the high frequency and levels of methylated mono-targeted therapies. 35,36 In light of accumulating evidence and our findings in this study, clinical validation of the efficacy of boswellic acids for both chemoprevention and therapy of CRC could be promising.…”
Section: (B) An Illustration From Ingenuitymentioning
“…The expression of miRNAs has also been identified to be dysregulated in colon cancer (Bartley et al 2011;Schetter et al 2008;Wu et al 2011). Another epigenetic mechanism of gene regulation is the modification of histones like (de)acetylation or (de)methylation which also plays a crucial role in colon cancer development (van Engeland et al 2011).…”
Epigenetic and posttranslational modifications of the expression of cell cycle-relevant genes or proteins like p21, e.g., by miRNAs are crucial mechanisms in the development or prevention of colon cancer. The present study investigated the influence of butyrate and trichostatin A (TSA) as histone deacetylase inhibitors on the expression of colon cancer-relevant miRNA (miR-135a, miR-135b, miR-24, miR-106b, miR-let-7a) in LT97 colon adenoma cells as a model of an early stage of colon carcinogenesis. The impact of distinct miRNAs (miR-106b, miR-135a) on butyrate-mediated regulation of p21 and Cyclin D2 gene and protein expression as well as the effect on LT97 cell proliferation (non-transfected, miR-106b and miR-135a mimic transfected) was analyzed. Butyrate and partial TSA reduced the expression of miR-135a, miR-135b, miR-24 and miR-let-7a (*0.5-fold, 24 h) and miR-24, miR-106b and miR-let-7a (*0.5-0.7-fold, 48 h) in LT97 cells. Levels of p21 mRNA and protein were significantly increased by butyrate and TSA (*threefold and 4.5-fold, respectively, 24 h) in non-transfected but not in miR-106b transfected LT97 cells. Levels of Cyclin D2 mRNA were significantly reduced by butyrate and TSA (*0.3-fold, 24 h) in non-transfected and miR-135a-transfected LT97 cells, whereas protein levels were predominantly not influenced. MiR-106b and miR-135a significantly reduced butyrate-/TSA-mediated inhibition of LT97 cell proliferation (72 h). These results indicate that butyrate is able to modify colon cancer-relevant miRNAs like miR-106b and miR-135a which are involved in the regulation of cell cycle-relevant genes like p21 and might influence inhibition of adenoma cell proliferation.
“…CRC is characterized by various forms of gene mutations, accompanied by genome instability, including chromosomal instability and microsatellite instability (Lao and Grady, 2011). CRC development is a multistep and complex process involving with the accumulation of genetic and epigenetic changes (Lao and Grady, 2011;Migheli and Migliore, 2012), especially at the early stage of CRC (van Engeland et al, 2011). Histopathology classification of CRC is divided into glandular epithelium carcinoma, squamous cell carcinoma, and carcinoid tumor (Armaghany et al, 2012).…”
Objective: The aim of this study was to determine whether six genetic polymorphisms confer susceptibility to colorectal cancer (CRC). Methods: A systematic search for candidate genes of CRC was performed among several online databases, including PubMed, Embase, Web of Science, the Cochrane Library, CNKI, and Wanfang online libraries. After a comprehensive filtering procedure, we harvested five genes, including MGMT (rs12917 and rs2308321), ADH1B (rs1229984), SOD2 (rs4880), XPC (rs2228001), and PPARG (rs1801282). Using the REVMAN and Stata software, six meta-analyses were conducted for associations between CRC and the just-mentioned genetic variants. Results: A total of 34 comparative studies among 17,289 cases and 54,927 controls were involved in our meta-analyses. Significant association was found between ADH1B rs1229984 polymorphism and CRC ( p = 0.03, odds ratio [OR] = 1.18, 95% confidence interval [CI] = 1.01-1.36). We also found significant association between PPARG rs1801282 polymorphism and CRC ( p = 0.004, OR = 1.498, 95% CI = 1.139-1.970), and this significant association is specific in Caucasians ( p = 0.004, OR = 1.603, 95% CI = 1.165-2.205). Conclusions: The current meta-analysis has established that ADH1B (rs1229984) and PPARG (rs1801282) are two risk variants of CRC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.